NCT04379336View on ClinicalTrials.gov

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

January 2, 2022

Study Completion Date

January 2, 2022

Conditions
COVID-19Sars-CoV2
Interventions
BIOLOGICAL

Bacille Calmette-Guérin (BCG)

BCG vaccine will be given intradermally in the upper arm after randomization.

OTHER

Placebo Comparator

Placebo injection will be given intradermally in the upper arm after randomization.

Trial Locations (1)

7500

TASK Foundation, Cape Town

All Listed Sponsors
lead

TASK Applied Science

OTHER

NCT04379336 - BCG Vaccination for Healthcare Workers in COVID-19 Pandemic | Biotech Hunter | Biotech Hunter